OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancer

Despite many advances in oncology, almost all patients with pancreatic cancer (PC) die of the disease. Molecularly targeted agents are offering hope for their potential role in helping translate the improved activity of combination chemotherapy into improved survival. Heat shock protein 27 (Hsp27) i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Baylot, V, Andrieu, C, Katsogiannou, M, Taieb, D, Garcia, S, Giusiano, S, Acunzo, J, Iovanna, J, Gleave, M, Garrido, C, Rocchi, P
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2011
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3219088/
https://ncbi.nlm.nih.gov/pubmed/22012255
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2011.104
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados